Journal Article (Erratum/Correction)

DKFZ-2019-02271

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Chretien, A.-S. ; Fauriat, C. ; Orlanducci, F. ; Rey, J. ; Borg, G. B. ; Gautherot, E. ; Granjeaud, S. ; Demerle, C. ; Hamel, J.-F. ; Cerwenka, A.DKFZ* ; von Strandmann, E. P. ; Ifrah, N. ; Lacombe, C. ; Cornillet-Lefebvre, P. ; Delaunay, J. ; Toubert, A. ; Arnoulet, C. ; Vey, N. ; Olive, D.

2019
Impact Journals LLC [S.l.]

This record in other databases:

Please use a persistent id in citations: doi:10.18632/oncotarget.27198

Abstract: [This corrects the article DOI: 10.18632/oncotarget.17747.].

---

Contributing Institute(s):

1. Nachwuchsgruppe Angeborene Immunität (D080)

Research Program(s):

1. 314 - Tumor immunology (POF3-314) (POF3-314)

Appears in the scientific report 2019

---

Database coverage:
; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS

---